{"created":"2023-07-27T06:54:56.339032+00:00","id":50525,"links":{},"metadata":{"_buckets":{"deposit":"4c0f2cb8-8857-48a9-aa11-30513ce6f2a6"},"_deposit":{"created_by":18,"id":"50525","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"50525"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00050525","sets":["2812:2813:2824"]},"author_link":["91478","381"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2010-05-14","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"5p.","bibliographicVolumeNumber":"2007-2009","bibliographic_titles":[{"bibliographic_title":"平成21(2009)年度 科学研究費補助金 基盤研究(C) 研究成果報告書"},{"bibliographic_title":"2009 Fiscal Year Final Research Report","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"我々はこれまでに、健常人を対象として、ラタノプロストによる眼圧下降作用と、その作用点であるプロスタグランジンFPレセプター遺伝子の2つの多型(rs3753380、rs3766355)の間に、関連性があることを報告した。そこで、緑内障や高眼圧症の患者において、同様の関連性が見られるかを検討したが、この2つの遺伝子多型と眼圧下降率の間に有意な関連は見出せなかった。","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:19592008, 研究期間(年度):2007-2009","subitem_description_type":"Other"},{"subitem_description":"出典：研究課題「緑内障治療薬の反応性と標的タンパクの遺伝子多型との関連」課題番号19592008\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所）） \n（https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-19592008/19592008seika/）を加工して作成","subitem_description_type":"Other"}]},"item_9_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"金沢大学附属病院","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00056834","subitem_identifier_reg_type":"JaLC"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/search/?qm=50303269"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/search/?qm=50303269","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19592008/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19592008/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-19592008/19592008seika/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-19592008/19592008seika/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-02-07"}],"displaytype":"detail","filename":"HO-PR-SAKURAI-M-kaken 2010-5p.pdf","filesize":[{"value":"234.8 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"HO-PR-SAKURAI-M-kaken 2010-5p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/50525/files/HO-PR-SAKURAI-M-kaken 2010-5p.pdf"},"version_id":"fcacad83-f9e5-4732-b7c4-1a404e7f9425"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"緑内障治療薬の反応性と標的タンパクの遺伝子多型との関連","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"緑内障治療薬の反応性と標的タンパクの遺伝子多型との関連"},{"subitem_title":"Association between response to antiglaucomatous drug and genetic polymorphisms of the target protein","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["2824"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-02-07"},"publish_date":"2020-02-07","publish_status":"0","recid":"50525","relation_version_is_last":true,"title":["緑内障治療薬の反応性と標的タンパクの遺伝子多型との関連"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T13:11:36.194862+00:00"}